|
AU2003256299A1
(en)
*
|
2002-07-01 |
2004-01-19 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to reg iv
|
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
|
US8029783B2
(en)
*
|
2005-02-02 |
2011-10-04 |
Genentech, Inc. |
DR5 antibodies and articles of manufacture containing same
|
|
PE20071101A1
(es)
*
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
|
US20080305320A1
(en)
*
|
2007-03-02 |
2008-12-11 |
Lucien Laude |
Nanoscale surface activation of silicone via laser processing
|
|
WO2008143733A2
(en)
*
|
2007-03-02 |
2008-11-27 |
Dohney Eye Institute |
Biocompatible implants and methods of making and attaching the same
|
|
AU2008293425B2
(en)
*
|
2007-08-31 |
2014-09-18 |
Amgen Inc. |
Solid-state protein formulation
|
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
|
WO2010108153A2
(en)
|
2009-03-20 |
2010-09-23 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
|
CN102066403B
(zh)
*
|
2009-04-03 |
2014-10-08 |
中国医学科学院基础医学研究所 |
抗人死亡受体dr5单克隆抗体ad5-10所识别的抗原决定簇、其衍生物及其用途
|
|
US8877199B2
(en)
|
2009-05-15 |
2014-11-04 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
B cell surface reactive antibodies
|
|
AU2010310457B2
(en)
|
2009-10-23 |
2015-07-02 |
Amgen Inc. |
Vial adapter and system
|
|
WO2011084623A1
(en)
|
2009-12-16 |
2011-07-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment
|
|
EP2534170B1
(en)
|
2010-02-12 |
2017-04-19 |
Pharmascience Inc. |
Iap bir domain binding compounds
|
|
CN103025369B
(zh)
|
2010-06-07 |
2016-07-06 |
安姆根有限公司 |
药物递送装置
|
|
MX360946B
(es)
*
|
2010-09-22 |
2018-10-29 |
Amgen Inc Star |
Inmunoglobulinas portadoras y usos de las mismas.
|
|
MX343114B
(es)
|
2010-10-05 |
2016-10-25 |
F Hoffmann-La Roche Ag * |
Anticuerpos contra la tweak humana y usos de los mismos.
|
|
WO2012057288A1
(ja)
|
2010-10-29 |
2012-05-03 |
第一三共株式会社 |
新規抗ｄｒ５抗体
|
|
CA2828405A1
(en)
|
2011-02-28 |
2012-09-07 |
Istituto Di Ricovero E Cura A Carattere Scientifico Materno-Infantile Bu Rlo Garofolo - Ospedale Di Alta Specializzazione E Di Rilievo Nazionale |
Apoptosis-inducing molecules and uses therefor
|
|
US9480624B2
(en)
|
2011-03-31 |
2016-11-01 |
Amgen Inc. |
Vial adapter and system
|
|
CA3145238A1
(en)
|
2011-04-20 |
2012-10-26 |
Amgen Inc. |
Autoinjector apparatus
|
|
RU2762685C2
(ru)
*
|
2011-07-12 |
2021-12-22 |
ИксБиотеч Инк. |
Выявление аффинно-зрелых человеческих антител
|
|
IL308846B2
(en)
|
2011-10-14 |
2025-03-01 |
Amgen Inc |
Injector and assembly method
|
|
WO2013063395A1
(en)
|
2011-10-27 |
2013-05-02 |
Nkt Therapeutics Inc. |
Humanized antibodies to inkt
|
|
WO2013061083A2
(en)
*
|
2011-10-28 |
2013-05-02 |
Fredax Ab |
Therapeutic agents and uses thereof
|
|
US20150056204A1
(en)
*
|
2012-03-28 |
2015-02-26 |
Amgen Inc. |
Dr5 receptor agonist combinations
|
|
US10377827B2
(en)
|
2012-06-21 |
2019-08-13 |
Sorrento Therapeutics, Inc. |
Antigen binding proteins that bind c-met
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
US12115341B2
(en)
|
2012-11-21 |
2024-10-15 |
Amgen Inc. |
Drug delivery device
|
|
TWI580452B
(zh)
|
2013-03-15 |
2017-05-01 |
安美基公司 |
用於注射器之匣盒、注射器及使用包括自動注射器及匣盒之設備之方法
|
|
TWI580451B
(zh)
|
2013-03-15 |
2017-05-01 |
安美基公司 |
用於注射器之匣盒及使用具有自動注射器及匣盒之自動注射器設備之方法
|
|
US9708375B2
(en)
|
2013-03-15 |
2017-07-18 |
Amgen Inc. |
Inhibitory polypeptides specific to WNT inhibitors
|
|
CA2903495C
(en)
|
2013-03-15 |
2021-05-25 |
Amgen Inc. |
Body contour adaptable autoinjector device
|
|
BR112015024282B1
(pt)
|
2013-03-22 |
2022-05-17 |
Amgen Inc |
Injetor e método de montagem do injetor
|
|
UA118028C2
(uk)
|
2013-04-03 |
2018-11-12 |
Рош Глікарт Аг |
Біспецифічне антитіло, специфічне щодо fap і dr5, антитіло, специфічне щодо dr5, і спосіб їх застосування
|
|
EP3041863A4
(en)
|
2013-09-05 |
2017-08-16 |
Amgen Inc. |
Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
|
|
AU2014340174B2
(en)
|
2013-10-24 |
2019-09-12 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
|
CN105873626A
(zh)
|
2013-10-24 |
2016-08-17 |
美国安进公司 |
注射器和组装方法
|
|
EP3088517B1
(en)
*
|
2013-12-26 |
2023-11-01 |
Mitsubishi Tanabe Pharma Corporation |
Human anti-il-33 neutralizing monoclonal antibody
|
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
SG11201609219QA
(en)
|
2014-05-07 |
2016-12-29 |
Amgen Inc |
Autoinjector with shock reducing elements
|
|
WO2015175861A1
(en)
|
2014-05-16 |
2015-11-19 |
Amgen Inc. |
Assay for detecting th1 and th2 cell populations
|
|
MX383560B
(es)
|
2014-05-16 |
2025-03-14 |
Ablynx Nv |
Dominios variables de inmunoglobulina mejorados.
|
|
IL318433A
(en)
|
2014-05-16 |
2025-03-01 |
Ablynx Nv |
Improved immunoglobulin variable complexes
|
|
CN106488782B
(zh)
|
2014-06-03 |
2021-03-09 |
安姆根有限公司 |
用于辅助药物递送装置的用户的装置和方法
|
|
US10695506B2
(en)
|
2014-10-14 |
2020-06-30 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
US10799630B2
(en)
|
2014-12-19 |
2020-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
JP2017538512A
(ja)
|
2014-12-19 |
2017-12-28 |
アムジエン・インコーポレーテツド |
ライブボタンまたはユーザインタフェースフィールドを含む薬物送達装置
|
|
UY36449A
(es)
|
2014-12-19 |
2016-07-29 |
Novartis Ag |
Composiciones y métodos para anticuerpos dirigidos a bmp6
|
|
SG10202001779UA
(en)
|
2015-01-20 |
2020-04-29 |
Igm Biosciences Inc |
Tumor necrosis factor (tnf) superfamily receptor binding molecules and uses thereof
|
|
EP3556411B1
(en)
|
2015-02-17 |
2021-06-30 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
ES2905870T3
(es)
|
2015-02-27 |
2022-04-12 |
Amgen Inc |
Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
TWI752920B
(zh)
|
2015-10-12 |
2022-01-21 |
美商再生元醫藥公司 |
活化瘦素受體的抗原結合蛋白
|
|
US20190144554A1
(en)
|
2015-12-01 |
2019-05-16 |
Genmab B.V. |
Anti-dr5 antibodies and methods of use thereof
|
|
WO2017100501A1
(en)
|
2015-12-09 |
2017-06-15 |
Amgen Inc. |
Auto-injector with signaling cap
|
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
US10849912B2
(en)
|
2016-02-09 |
2020-12-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment
|
|
ES2814287T3
(es)
|
2016-03-15 |
2021-03-26 |
Amgen Inc |
Reducir la probabilidad de rotura de cristal en dispositivos de administración de fármaco
|
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
MX2018013616A
(es)
|
2016-05-13 |
2019-02-21 |
Amgen Inc |
Montaje de cubierta protectora de vial.
|
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
EP3465124A1
(en)
|
2016-06-03 |
2019-04-10 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
AU2017283787B2
(en)
|
2016-06-15 |
2020-09-17 |
Novartis Ag |
Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)
|
|
EP3478342B1
(en)
|
2016-07-01 |
2025-03-12 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
|
US11352425B2
(en)
|
2016-11-08 |
2022-06-07 |
Absos, Llc |
Anti-CD47 antibodies
|
|
AU2017359439B2
(en)
|
2016-11-08 |
2024-11-28 |
Regeneron Pharmaceuticals, Inc. |
Antigen-binding proteins that antagonize leptin receptor
|
|
EP3570917A1
(en)
|
2017-01-17 |
2019-11-27 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
EP3579866A4
(en)
*
|
2017-02-08 |
2020-12-09 |
Dragonfly Therapeutics, Inc. |
HEAVY CHAIN VARIABLE ANTIBODY DOMAINS WITH NKG2D RECEPTOR AIMING
|
|
KR20240023449A
(ko)
|
2017-02-08 |
2024-02-21 |
드래곤플라이 쎄라퓨틱스, 인크. |
천연 킬러 세포의 활성화를 위한 다중-특이적 결합 단백질 및 암 치료에서의 그의 치료적 용도
|
|
KR20250140128A
(ko)
|
2017-02-10 |
2025-09-24 |
젠맵 비. 브이 |
폴리펩티드 변이체 및 그의 용도
|
|
EP3582825A1
(en)
|
2017-02-17 |
2019-12-25 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
JP7685821B2
(ja)
|
2017-02-20 |
2025-05-30 |
ドラゴンフライ セラピューティクス， インコーポレイテッド |
Ｈｅｒ２、ＮＫＧ２ＤおよびＣＤ１６に結合するタンパク質
|
|
WO2018165143A1
(en)
|
2017-03-06 |
2018-09-13 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
|
EP3592402A1
(en)
|
2017-03-07 |
2020-01-15 |
Amgen Inc. |
Needle insertion by overpressure
|
|
IL268386B2
(en)
|
2017-03-09 |
2023-11-01 |
Amgen Inc |
Insertion mechanism for a drug delivery device
|
|
AU2018235928B2
(en)
|
2017-03-14 |
2023-09-21 |
Amgen Inc. |
Control of total afucosylated glycoforms of antibodies produced in cell culture
|
|
US11957883B2
(en)
|
2017-03-28 |
2024-04-16 |
Amgen Inc. |
Plunger rod and syringe assembly system and method
|
|
TWI796329B
(zh)
|
2017-04-07 |
2023-03-21 |
美商默沙東有限責任公司 |
抗－ilt4抗體及抗原結合片段
|
|
BR112019025328A2
(pt)
|
2017-06-07 |
2020-06-23 |
Genmab B.V. |
Composição farmacêutica, uso da composição farmacêutica, métodos para tratar um indivíduo tendo um câncer e para preparar uma composição farmacêutica, e, kit de partes.
|
|
EP3634539A1
(en)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
CN110709121B
(zh)
|
2017-06-08 |
2022-06-24 |
安进公司 |
扭矩驱动式药物递送装置
|
|
AU2018288604B2
(en)
|
2017-06-22 |
2023-12-21 |
Amgen Inc. |
Device activation impact/shock reduction
|
|
MX2019015479A
(es)
|
2017-06-23 |
2020-02-20 |
Amgen Inc |
Dispositivo electronico de administracion de farmacos con tapa accionada por un conjunto de conmutador.
|
|
WO2019014014A1
(en)
|
2017-07-14 |
2019-01-17 |
Amgen Inc. |
NEEDLE INSERTION-RETRACTING SYSTEM HAVING DOUBLE TORSION SPRING SYSTEM
|
|
EP4292576A3
(en)
|
2017-07-21 |
2024-01-17 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
|
US11484648B2
(en)
|
2017-07-25 |
2022-11-01 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
|
US11617837B2
(en)
|
2017-07-25 |
2023-04-04 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
|
EP3664863A2
(en)
|
2017-08-09 |
2020-06-17 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
|
EP3668567A1
(en)
|
2017-08-18 |
2020-06-24 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
MA50611A
(fr)
|
2017-10-04 |
2020-08-12 |
Amgen Inc |
Adaptateur d'écoulement destiné à un dispositif d'administration de médicament
|
|
CN111132711B
(zh)
|
2017-10-06 |
2022-07-01 |
安进公司 |
带有联锁组件的药物递送装置及相关组装方法
|
|
WO2019074579A1
(en)
|
2017-10-09 |
2019-04-18 |
Amgen Inc. |
DRUG DELIVERY DEVICE COMPRISING A DRIVE ASSEMBLY AND ASSEMBLY METHOD THEREOF
|
|
US11826480B2
(en)
|
2017-11-03 |
2023-11-28 |
Amgen Inc. |
Systems and approaches for sterilizing a drug delivery device
|
|
WO2019089178A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
|
WO2019090303A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
|
WO2019094138A1
(en)
|
2017-11-10 |
2019-05-16 |
Amgen Inc. |
Plungers for drug delivery devices
|
|
EP3710089A1
(en)
|
2017-11-16 |
2020-09-23 |
Amgen Inc. |
Autoinjector with stall and end point detection
|
|
EP3710090A1
(en)
|
2017-11-16 |
2020-09-23 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
|
CN107909501B
(zh)
*
|
2017-12-05 |
2020-12-01 |
创新先进技术有限公司 |
气味与行为的关联方法、气味社交方法及装置
|
|
SG11202005146VA
(en)
|
2017-12-18 |
2020-06-29 |
Regeneron Pharma |
Bispecific antigen binding molecules that bind leptin receptor and/or gp130, and methods of use thereof
|
|
CN111936519A
(zh)
|
2018-02-01 |
2020-11-13 |
辉瑞公司 |
对cd70具有特异性的抗体及其用途
|
|
PT3749346T
(pt)
|
2018-02-08 |
2024-09-05 |
Dragonfly Therapeutics Inc |
Combinações de domínios variáveis de anticorpos dirigidas ao receptor nkg2d
|
|
KR20200118824A
(ko)
|
2018-02-08 |
2020-10-16 |
드래곤플라이 쎄라퓨틱스, 인크. |
자연 살해 세포를 활성화시키는 다중-특이성 결합 단백질을 수반하는 암의 병용 요법
|
|
CA3091424A1
(en)
|
2018-02-20 |
2019-08-29 |
Dragonfly Therapeutics, Inc. |
Multi-specific binding proteins that bind cd33, nkg2d, and cd16, and methods of use
|
|
CN111757941A
(zh)
*
|
2018-02-26 |
2020-10-09 |
Igm生物科学股份有限公司 |
多聚体抗dr5结合分子与化学治疗剂联合用于治疗癌症的用途
|
|
WO2019173499A1
(en)
|
2018-03-06 |
2019-09-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
17-beta-hydroxywithanolides and use thereof in treating cancer
|
|
WO2019191150A1
(en)
|
2018-03-26 |
2019-10-03 |
Amgen Inc. |
Total afucosylated glycoforms of antibodies produced in cell culture
|
|
AU2019249273A1
(en)
|
2018-04-06 |
2020-10-15 |
Regeneron Pharmaceuticals, Inc. |
Methods of treatment using a leptin receptor agonist antibody
|
|
MX2020012589A
(es)
|
2018-05-24 |
2021-01-29 |
Janssen Biotech Inc |
Anticuerpos anti-tmeff2 monoespecificos y multiespecificos y sus usos.
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
WO2020014443A1
(en)
*
|
2018-07-12 |
2020-01-16 |
Vanderbilt University |
Pan-ebolavirus neutralizing human antibodies and methods of use therefor
|
|
MX2021000748A
(es)
|
2018-07-24 |
2021-03-26 |
Amgen Inc |
Dispositivos de suministro para administrar farmacos.
|
|
CA3103682A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
EP3829692A1
(en)
|
2018-07-31 |
2021-06-09 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
SG11202101298XA
(en)
|
2018-08-08 |
2021-03-30 |
Dragonfly Therapeutics Inc |
Proteins binding nkg2d, cd16 and a tumor-associated antigen
|
|
EP3833392A4
(en)
|
2018-08-08 |
2022-05-18 |
Dragonfly Therapeutics, Inc. |
Multi-specific binding proteins that bind bcma, nkg2d and cd16, and methods of use
|
|
EA202091888A1
(ru)
|
2018-08-08 |
2020-10-23 |
Драгонфлай Терапьютикс, Инк. |
Вариабельные домены антител, нацеленные на рецептор nkg2d
|
|
MA53724A
(fr)
|
2018-09-24 |
2021-12-29 |
Amgen Inc |
Systèmes et procédés de dosage interventionnel
|
|
WO2020068476A1
(en)
|
2018-09-28 |
2020-04-02 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
|
CN117159846A
(zh)
|
2018-10-02 |
2023-12-05 |
安进公司 |
具有内部力传递的用于药物递送的注射系统
|
|
MA53818A
(fr)
|
2018-10-05 |
2022-01-12 |
Amgen Inc |
Dispositif d'administration de médicament ayant un indicateur de dose
|
|
SG11202103800RA
(en)
|
2018-10-15 |
2021-05-28 |
Amgen Inc |
Drug delivery device having damping mechanism
|
|
EP3866889A1
(en)
|
2018-10-15 |
2021-08-25 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
|
EP3873566B1
(en)
|
2018-11-01 |
2024-11-27 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
MA54057A
(fr)
|
2018-11-01 |
2022-02-09 |
Amgen Inc |
Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
|
|
MX2021012557A
(es)
|
2019-04-24 |
2021-11-12 |
Amgen Inc |
Conjuntos y metodos de verificacion de esterilizacion de jeringuillas.
|
|
AU2020337250A1
(en)
|
2019-08-23 |
2022-03-03 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
|
WO2021062372A1
(en)
|
2019-09-26 |
2021-04-01 |
Amgen Inc. |
Methods of producing antibody compositions
|
|
CA3177024A1
(en)
|
2020-05-06 |
2021-11-11 |
Dragonfly Therapeutics, Inc. |
Proteins binding nkg2d, cd16 and clec12a
|
|
EP4162257A1
(en)
|
2020-06-04 |
2023-04-12 |
Amgen Inc. |
Assessment of cleaning procedures of a biotherapeutic manufacturing process
|
|
MX2023004364A
(es)
|
2020-10-15 |
2023-05-03 |
Amgen Inc |
Glucanos no emparejados relativos en metodos de produccion de anticuerpos.
|
|
CN112521500B
(zh)
*
|
2020-12-25 |
2022-06-24 |
暨南大学 |
与cxcr4结合的亲和力成熟结合蛋白及应用
|
|
CN112661845B
(zh)
*
|
2020-12-25 |
2022-06-21 |
暨南大学 |
与cxcr4结合的亲和力成熟结合蛋白及其应用
|
|
WO2022187539A1
(en)
|
2021-03-03 |
2022-09-09 |
Dragonfly Therapeutics, Inc. |
Methods of treating cancer using multi-specific binding proteins that bind nkg2d, cd16 and a tumor-associated antigen
|
|
AU2022279223A1
(en)
|
2021-05-21 |
2023-10-19 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
|
MX2023014515A
(es)
|
2021-06-07 |
2024-01-29 |
Amgen Inc |
Uso de fucosidasa para controlar el nivel de afucosilacion de proteinas glucosiladas.
|
|
AU2022361382A1
(en)
|
2021-10-05 |
2024-03-28 |
Amgen Inc. |
Fc-gamma receptor ii binding and glycan content
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
CN117285643A
(zh)
|
2022-06-16 |
2023-12-26 |
清华大学 |
一种相变调节套件及其用途
|
|
WO2025038600A1
(en)
|
2023-08-14 |
2025-02-20 |
Amgen Inc. |
Methods for reducing yellow color
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|